Harris, D., Lacey, A., Akbari, A., Gravenor, M., & Halcox, J. (2018). EARLY DISCONTINUATION OF P2Y12 ANTAGONISTS AND ADVERSE CLINICAL OUTCOMES POST PERCUTANEOUS CORONARY INTERVENTION. Journal of the American College of Cardiology, 71(11), p. A74. doi:10.1016/s0735-1097(18)30615-6

Harris, Daniel, Arron Lacey, Ashley Akbari, Michael Gravenor, and Julian Halcox. "EARLY DISCONTINUATION OF P2Y12 ANTAGONISTS AND ADVERSE CLINICAL OUTCOMES POST PERCUTANEOUS CORONARY INTERVENTION." Journal of the American College of Cardiology 71, no. 11 (2018): A74.

Harris, Daniel, et al. "EARLY DISCONTINUATION OF P2Y12 ANTAGONISTS AND ADVERSE CLINICAL OUTCOMES POST PERCUTANEOUS CORONARY INTERVENTION." Journal of the American College of Cardiology 71.11 (2018): A74.